We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

155 hedge funds and large institutions have $809M invested in Pacific Biosciences in 2018 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 45 increasing their positions, 25 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 34

89% more call options, than puts

Call options by funds: $8.75M | Put options by funds: $4.62M

80% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 25

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

37% more capital invested

Capital invested by funds: $590M → $809M (+$220M)

31% more funds holding

Funds holding: 118 → 155 (+37)

1.4% less ownership

Funds ownership: 74.5% → 73.1% (-1.4%)

Holders
155
Holders Change
+37
Holders Change %
+31.36%
% of All Funds
3.45%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
71
Increased
45
Reduced
25
Closed
34
Calls
$8.75M
Puts
$4.62M
Net Calls
+$4.12M
Net Calls Change
+$4.54M

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$58.8M
2
AA
AQR Arbitrage
Connecticut
+$41.7M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$28.2M
4
AAM
Alpine Associates Management
Florida
+$27M
5
UOC
UBS O'Connor
Illinois
+$19M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$70.1M
2
MC
Maverick Capital
Texas
-$65.9M
3
AIM
ARK Investment Management
Florida
-$49.3M
4
OIM
Oracle Investment Management
Connecticut
-$43.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$28M
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
51
GAMCO Investors
Connecticut
$2.44M +$2.09M +329,450 New
MOACM
52
Mutual of America Capital Management
New York
$2.37M -$948K -149,620 -32%
TA
53
Teachers Advisors
New York
$2.35M +$553K +87,311 +38%
PAM
54
Panagora Asset Management
Massachusetts
$2.31M -$876K -138,220 -31%
Morgan Stanley
55
Morgan Stanley
New York
$2.26M +$464K +73,283 +31%
BCM
56
Bridgeway Capital Management
Texas
$2.26M -$412K -65,000 -18%
PWPCM
57
Perella Weinberg Partners Capital Management
New York
$2.25M +$1.93M +303,823 New
State of Wisconsin Investment Board
58
State of Wisconsin Investment Board
Wisconsin
$2.22M +$1.9M +300,000 New
CS
59
Candriam SCA
Luxembourg
$2.13M +$1.82M +287,355 New
JP Morgan Chase
60
JP Morgan Chase
New York
$2.02M +$1.49M +235,508 +640%
Squarepoint
61
Squarepoint
New York
$1.97M +$1.68M +265,534 New
CS
62
Credit Suisse
Switzerland
$1.91M +$1.26M +199,313 +340%
PPA
63
Parametric Portfolio Associates
Washington
$1.81M -$141K -22,329 -8%
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.72M +$52K +8,200 +4%
Walleye Trading
65
Walleye Trading
New York
$1.68M +$1.42M +223,439 +5,680%
TCIM
66
TIAA CREF Investment Management
New York
$1.68M +$12.7K +2,009 +0.9%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$1.58M +$161K +25,466 +13%
ACPU
68
Arrowgrass Capital Partners (US)
Delaware
$1.41M +$1.21M +190,451 New
MSAM
69
Moloney Securities Asset Management
Missouri
$1.38M -$1.78M -281,037 -60%
KAM
70
Kassirer Asset Management
Ontario, Canada
$1.35M +$1.16M +182,950 New
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$1.29M +$411K +64,940 +59%
GH
72
GAM Holding
Switzerland
$1.28M +$1.09M +172,500 New
FFH
73
Fairfax Financial Holdings
Ontario, Canada
$1.18M +$1.01M +160,000 New
PP
74
Paloma Partners
Connecticut
$1.15M +$983K +155,100 New
BPGAM
75
BTG Pactual Global Asset Management
Bermuda
$1.14M +$972K +153,400 New
1 2
3
4 5

PACB Hedge Fund Activity: Q4 2018 in Review

155 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q4 2018, worth a combined $809M — up 37% from $590M a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new PACB positions and 34 closed out — a net gain of 37 holders — while 45 added to existing stakes and 25 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $58.8M. The largest seller was Consonance Capital Management, cutting an estimated $70.1M.

  • 155 institutional investors held Pacific Biosciences (PACB) as of Q4 2018, up from 118 in Q3 2018.
  • Funds reported $809M of Pacific Biosciences stock for Q4 2018, up 37% quarter-over-quarter.
  • 71 funds opened new Pacific Biosciences positions in Q4 2018 and 34 closed out, a net change of +37 holders.
  • The largest Pacific Biosciences buyer in Q4 2018 was Magnetar Financial, an estimated $58.8M added.
  • The largest Pacific Biosciences seller in Q4 2018 was Consonance Capital Management, an estimated $70.1M sold.

Based on aggregated 13F filings for Q4 2018.